Sun Y - Search Results

1

Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1/β-catenin pathway in glioblastoma.

Sun Y, Mu G, Zhang X, Wu Y, Wang S, Wang X, Xue Z, Wang C, Liu J, Li W, Zhang L, Guo Y, Zhao F, Liu X, Xue Z, Zhang Y, Ni S, Wang J, Li X, Han M, Huang B. Sun Y, et al. Neuro Oncol. 2024 Apr 5;26(4):653-669. doi: 10.1093/neuonc/noad232. Neuro Oncol. 2024. PMID: 38069906

2

Pharmacological targeting of Tripartite Motif Containing 24 for the treatment of glioblastoma.

Han M, Sun Y. Han M, et al. Among authors: sun y. J Transl Med. 2021 Dec 9;19(1):505. doi: 10.1186/s12967-021-03158-w. J Transl Med. 2021. PMID: 34886858 Free PMC article.

3

Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention.

Wang X, Han M, Wang S, Sun Y, Zhao W, Xue Z, Liang X, Huang B, Li G, Chen A, Li X, Wang J. Wang X, et al. Among authors: sun y. Theranostics. 2022 Jul 11;12(12):5451-5469. doi: 10.7150/thno.72248. eCollection 2022. Theranostics. 2022. PMID: 35910786 Free PMC article.

4

The copper-associated protein STEAP2 correlated with glioma prognosis and immune infiltration.

Wang X, Han M, Chen S, Sun Y, Tan R, Huang B. Wang X, et al. Among authors: sun y. Front Cell Neurosci. 2022 Aug 18;16:944682. doi: 10.3389/fncel.2022.944682. eCollection 2022. Front Cell Neurosci. 2022. PMID: 36060273 Free PMC article.

5

Comprehensive characterization of TNFSF14/LIGHT with implications in prognosis and immunotherapy of human gliomas.

Han M, Sun Y, Zhao W, Xiang G, Wang X, Jiang Z, Xue Z, Zhou W. Han M, et al. Among authors: sun y. Front Immunol. 2022 Oct 20;13:1025286. doi: 10.3389/fimmu.2022.1025286. eCollection 2022. Front Immunol. 2022. PMID: 36341396 Free PMC article.

6

Pharmacological targeting of one‑carbon metabolism as a novel therapeutic strategy for glioblastoma.

Sun Y, Mu G, Xue Z, Li X, Lin X, Han M. Sun Y, et al. J Transl Med. 2023 Jun 29;21(1):424. doi: 10.1186/s12967-023-04185-5. J Transl Med. 2023. PMID: 37386497 Free PMC article. No abstract available.

7

Targeting cholesterol homeostasis through inhibiting SREBP-2: An Achilles' heel for glioblastoma.

Sun Y, Mu G, Xue Z, Wang S, Li X, Han M. Sun Y, et al. Neuro Oncol. 2023 Nov 2;25(11):2100-2102. doi: 10.1093/neuonc/noad145. Neuro Oncol. 2023. PMID: 37623320 Free PMC article. No abstract available.

8

Network pharmacology and experimental verification reveal the mechanism of safranal against glioblastoma (GBM).

Yang X, Lu D, Sun Y, Wei T, Man D, Chen A, Luo T, Zhao F, Liu X, Cheng B, Wang X, Zhao P, Wang D, Li X. Yang X, et al. Among authors: sun y. Front Oncol. 2023 Sep 5;13:1255164. doi: 10.3389/fonc.2023.1255164. eCollection 2023. Front Oncol. 2023. PMID: 37736545 Free PMC article.

9

Polyunsaturated fatty acid-binding protein FABP7, an attractive metabolic target for inhibition of glioblastoma stem cells.

Sun Y, Mu G, Xue Z, Wang S, Li X, Ni S, Han M. Sun Y, et al. Neuro Oncol. 2024 Mar 4;26(3):587-589. doi: 10.1093/neuonc/noad238. Neuro Oncol. 2024. PMID: 38244234 Free PMC article. No abstract available.

10

The dopamine receptor D1 inhibitor, SKF83566, suppresses GBM stemness and invasion through the DRD1-c-Myc-UHRF1 interactions.

Xue Z, Zhang Y, Zhao R, Liu X, Grützmann K, Klink B, Zhang X, Wang S, Zhao W, Sun Y, Han M, Wang X, Hu Y, Liu X, Yang N, Qiu C, Li W, Huang B, Li X, Bjerkvig R, Wang J, Zhou W. Xue Z, et al. Among authors: sun y. J Exp Clin Cancer Res. 2024 Jan 22;43(1):25. doi: 10.1186/s13046-024-02947-7. J Exp Clin Cancer Res. 2024. PMID: 38246990 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64,445 results

Search Page

Filters